These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24169058)

  • 21. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone.
    Fukushima C; Matsuse H; Tomari S; Obase Y; Miyazaki Y; Shimoda T; Kohno S
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):646-51. PubMed ID: 12839324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children.
    Fogel RB; Rosario N; Aristizabal G; Loeys T; Noonan G; Gaile S; Smugar SS; Polos PG
    Ann Allergy Asthma Immunol; 2010 Jun; 104(6):511-7. PubMed ID: 20568384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial.
    Kooi EM; Schokker S; Marike Boezen H; de Vries TW; Vaessen-Verberne AA; van der Molen T; Duiverman EJ
    Pulm Pharmacol Ther; 2008 Oct; 21(5):798-804. PubMed ID: 18647656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML; Wahn U; Gilles L; Swern A; Tozzi CA; Polos P
    Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
    Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic efficacy and follow-up study of inhaled corticosteroids vs. oral montelukast in treatment of cough variant asthma].
    Sun LH; Chen AH; Zhang Y
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):85-8. PubMed ID: 19099676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of inhaled corticosteroids on growth in asthmatic children: a comparison of fluticasone propionate with budesonide.
    Acun C; Tomac N; Ermis B; Onk G
    Allergy Asthma Proc; 2005; 26(3):204-6. PubMed ID: 16119035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
    Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.
    Schuh S; Dick PT; Stephens D; Hartley M; Khaikin S; Rodrigues L; Coates AL
    Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of montelukast for treatment of asthma in cigarette smokers.
    Price D; Popov TA; Bjermer L; Lu S; Petrovic R; Vandormael K; Mehta A; Strus JD; Polos PG; Philip G
    J Allergy Clin Immunol; 2013 Mar; 131(3):763-71. PubMed ID: 23380218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
    Stempel DA; Riedel AA; Carranza Rosenzweig JR
    Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of mometasone, fluticasone, and montelukast on bone mineral density in adults with asthma.
    Maspero J; Backer V; Yao R; Staudinger H; Teper A
    J Allergy Clin Immunol Pract; 2013; 1(6):649-55.e1. PubMed ID: 24565713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
    Allen-Ramey FC; Duong PT; Riedel AA; Markson LE; Weiss KB
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma.
    Papi A; Paggiaro P; Nicolini G; Vignola AM; Fabbri LM;
    Allergy; 2007 Oct; 62(10):1182-8. PubMed ID: 17845589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential prescribing of inhaled corticosteroids in New Zealand general practice.
    Hall J; Penrose A; Tomlin A; Reid J
    N Z Med J; 2003 Aug; 116(1180):U563. PubMed ID: 14581985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The systemic exposure to inhaled beclometasone/formoterol pMDI with valved holding chamber is independent of age and body size.
    Govoni M; Piccinno A; Lucci G; Poli G; Acerbi D; Baronio R; Singh D; Kuna P; Chawes BL; Bisgaard H
    Pulm Pharmacol Ther; 2015 Feb; 30():102-9. PubMed ID: 24746942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.